StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)

Close on Nov 18, 2026Market cap $140.15MP/E –Yield –

Drugs Made In America Acquisition II pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Drugs Made In America Acquisition II's pe ratio was 10.8× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.8×–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?